Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,095 JPY | +1.66% | -1.73% | +1.01% |
11:02am | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
10:45am | Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.01% | 39.61B | |
+52.61% | 796B | |
+41.28% | 628B | |
-5.12% | 358B | |
+20.45% | 331B | |
+11.13% | 301B | |
+17.85% | 244B | |
+3.84% | 228B | |
+13.21% | 214B | |
+7.13% | 165B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20